Determination of the “reflex range” and appropriate cutpoints for percent free prostatespecific antigen in 413 men referred for prostatic evaluation using the AxSYM system
- 1 January 1997
- Vol. 49 (1), 19-27
- https://doi.org/10.1016/s0090-4295(96)00511-0
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Cancer statistics, 1996CA: A Cancer Journal for Clinicians, 1996
- The Nature of Prostate Cancer Detected Through Prostate Specific Antigen Based ScreeningJournal of Urology, 1994
- Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 MenJournal of Urology, 1994
- Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancerPublished by American Medical Association (AMA) ,1994
- PSA DENSITY (PSAD)Urologic Clinics of North America, 1993
- Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screeningPublished by American Medical Association (AMA) ,1993
- Clinical stage Bo or T1c prostate cancer: Nonpalpable disease identified by elevated serum prostate-specific antigen concentrationUrology, 1993
- Screening for Prostatic Carcinoma with Prostate Specific AntigenJournal of Urology, 1992
- The Use of Prostate Specific Antigen Density to Enhance the Predictive Value of Intermediate Levels of Serum Prostate Specific AntigenJournal of Urology, 1992
- Prostate Specific Antigen: A Critical Assessment of the Most Useful Tumor Marker for Adenocarcinoma of the ProstateJournal of Urology, 1991